Journal article
Compounded Nonsterile Preparations and FDA-Approved Commercially Available Liquid Products for Children: A North American Update
Pharmaceutics, v 14(5), p1032
10 May 2022
PMID: 35631618
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
The purpose of this work was to evaluate the suitability of recent US Food and Drug Administration (US-FDA)-approved and marketed oral liquid, powder, or granule products for children in North America, to identify the next group of Active Pharmaceutical Ingredients (APIs) that have high potential for development as commercially available FDA-approved finished liquid dosage forms, and to propose lists of compounded nonsterile preparations (CNSPs) that should be developed as commercially available FDA-approved finished liquid dosage forms, as well as those that pharmacists should continue to compound extemporaneously. Through this identification and categorization process, the pharmaceutical industry, government, and professionals are encouraged to continue to work together to improve the likelihood that patients will receive high-quality standardized extemporaneously compounded CNSPs and US-FDA-approved products.
Metrics
Details
- Title
- Compounded Nonsterile Preparations and FDA-Approved Commercially Available Liquid Products for Children: A North American Update
- Creators
- Richard H Parrish, 2nd - Department of Biomedical Sciences, Mercer University School of Medicine, Columbus, GA 31902, USALisa D Ashworth - Department of Pharmacy Services, Children’s Health System of Texas, Dallas, TX 75235, USARaimar Löbenberg - University of AlbertaSandra Benavides - Philadelphia College of Osteopathic MedicineJeffrey J Cies - St. Christopher's Hospital for ChildrenRobert B MacArthur - Rockefeller University Hospital
- Publication Details
- Pharmaceutics, v 14(5), p1032
- Publisher
- MDPI
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- College of Medicine
- Web of Science ID
- WOS:000803331500001
- Scopus ID
- 2-s2.0-85130327379
- Other Identifier
- 991019350683804721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- International collaboration
- Web of Science research areas
- Pharmacology & Pharmacy